-
CLOSING THE LANGUAGE GAP IN HEOR REVIEWS: VALIDATING AI-ASSISTED SCREENING OF CHINESE-LANGUAGE EVIDENCE
Aug 11, 2026, 17:16 PM -
TREATMENT PREFERENCES FOR PHARMACOLOGICAL THERAPIES IN ALZHEIMER'S DISEASE: A SCOPING REVIEW OF STATED-PREFERENCE STUDIES
Aug 11, 2026, 17:16 PM -
INDIRECT COMPARISONS FOR HEALTH TECHNOLOGY ASSESSMENT: A PRACTICAL METHODOLOGICAL GUIDE AND TIPS WITH INSIGHTS FROM THE FRENCH TRANSPARENCY COMMISSION
Aug 11, 2026, 17:16 PM -
DIFFERENT LEVERS, SAME DIRECTION: HOW THREE EUROPEAN HTA ARCHETYPES TRANSLATE UNMET NEED INTO ADDED-VALUE VERDICTS FOR GENE THERAPIES
Aug 11, 2026, 17:16 PM -
INTEGRATING EQUITY INTO HTA VALUE ASSESSMENT IN EUROPE: A TARGETED LITERATURE REVIEW OF FRAMEWORKS, METHODS, AND POLICY APPLICATIONS ACROSS MAJOR HTA AGENCIES
Aug 11, 2026, 17:16 PM -
ASSESSING THE AVOIDABLE HEALTHCARE COSTS OF OFF-LABEL QUETIAPINE IN DEMENTIA: A RETROSPECTIVE ANALYSIS OF MIS-CHANNELLING DISPENTIONS
Aug 11, 2026, 17:16 PM -
PROJECTING THE FUTURE BURDEN OF NON-MUSCLE INVASIVE BLADDER CANCER IN EUROPE: AN EPIDEMIOLOGICAL MODEL FRAMEWORK BASED ON REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
ASSESSING THE REAL-WORLD EFFECTIVENESS OF SPESOLIMAB IN GENERALIZED PUSTULAR PSORIASIS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
ASSESSING HEALTH-RELATED QUALITY OF LIFE AMONG CHILDREN AND ADOLESCENTS WITH VISION IMPAIRMENT USING THE EQ-5D-Y-3L INSTRUMENT IN BRAZIL
Aug 11, 2026, 17:16 PM -
CURRENT TREATMENT PATTERNS AND SAFETY OUTCOMES IN RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) WITH AN NPM1 MUTATION: A SYSTEMATIC LITERATURE REVIEW (SLR)
Aug 11, 2026, 17:16 PM -
HOW MUCH DO MEDICATIONS COST PATIENTS IN FINLAND? A NATIONWIDE REGISTER-BASED STUDY OF OUT-OF-POCKET COSTS
Aug 11, 2026, 17:16 PM -
COSTS AND COST DRIVERS OF INFLAMMATORY BOWEL DISEASE IN THE UNITED KINGDOM: EVIDENCE FROM A LARGE PATIENT SURVEY USING TWEEDIE REGRESSION
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF ETRANACOGENE DEZAPARVOVEC VERSUS FACTOR IX PROPHYLAXIS FOR SEVERE OR MODERATELY SEVERE HAEMOPHILIA B IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
BENCHMARKING DAY SURGERY POTENTIAL IN HUNGARY USING THE BEDS METHODOLOGY: THEORETICAL RESERVES IN CASE VOLUMES AND HOSPITALIZATION DAYS, 2015-2025
Aug 11, 2026, 17:16 PM -
IDENTIFICATION OF TREATMENT EFFECT MODIFIERS (TEMS) AND PROGNOSTIC FACTORS (PFS) IN MATCHING-ADJUSTED INDIRECT COMPARISONS (MAICS)- A SYSTEMATIC LITERATURE REVIEW (SLR)
Aug 11, 2026, 17:16 PM -
EXPLORING THE IMPACT OF EVOLVING TREATMENT PATHWAYS ON COMPARATOR RELEVANCE IN EUROPEAN ONCOLOGY HEALTH TECHNOLOGY ASSESSMENTS (HTAS)
Aug 11, 2026, 17:16 PM -
ANXIETY AND DEPRESSIVE SYMPTOM BURDEN AND ITS ASSOCIATION WITH FUNCTIONAL IMPAIRMENT IN PULMONARY FIBROSIS IN GREECE
Aug 11, 2026, 17:16 PM -
REVISITING THE CASE FOR REFORM: THE IMPACT ASSESSMENT BEHIND THE EU HTA REGULATION
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN HR+/HER2- BREAST CANCER: EVIDENCE FROM MEXICO
Aug 11, 2026, 17:16 PM -
RAPID AND HIGH-FIDELITY REPLICATION OF ECONOMIC MODELS USING AN LLM-ENABLED MODEL BUILDING PLATFORM
Aug 11, 2026, 17:16 PM
